Published:
Last updated:
-
ID
NL-OMON48210
Source
ToetsingOnline
Brief title
-
Condition
- Other condition
Synonym
-
Health condition
alle kinderen met intermitternde IV-medicatie
Research involving
Human
Sponsors and support
Primary sponsor
:
Isala Klinieken
Source(s) of monetary or material Support
:
Innovatie- en wetenschapsfonds Isala
Intervention
Keyword
:
-
Outcome measures
Primary outcome
-
Secondary outcome
-
Background summary
-
Study objective
-
Study design
-
Intervention
-
Study burden and risks
not applicable
Public
Isala Klinieken
Dr van heesweg 2
Zwolle 8025AB
NL
Dr van heesweg 2
Zwolle 8025AB
NL
Scientific
Isala Klinieken
Dr van heesweg 2
Zwolle 8025AB
NL
Dr van heesweg 2
Zwolle 8025AB
NL
Listed location countries
Netherlands
Age
Adolescents (12-15 years)
Adolescents (16-17 years)
Children (2-11 years)
Inclusion criteria
-
Exclusion criteria
-
Design
Study type
:
Interventional
Intervention model
:
Parallel
Allocation
:
Randomized controlled trial
Masking
:
Open (masking not used)
Control
:
Active
Primary purpose
:
Treatment
Recruitment
NL
Recruitment status
:
Recruiting
Start date (anticipated)
:
Enrollment
:
252
Type
:
Actual
Approved WMO
Date
:
Application type
:
First submission
Review commission
:
METC Universitair Medisch Centrum Groningen (Groningen)
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL70755.075.19 |